Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02416583
Other study ID # SWP_PG_N2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2015
Est. completion date July 2018

Study information

Verified date February 2020
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare concurrent oxytocin with membrane sweeping versus dinoprostone pessary in labor induction for nulliparas at term with an unfavorable cervix


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date July 2018
Est. primary completion date July 2018
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- singleton pregnancy

- Nulliparous women

- gestational age >=37.0 weeks

- Bishop score <=6

- intact amniotic membrane

- absence of labor

- live fetus with vertex presentation

- no previous uterine surgical procedure

Exclusion Criteria:

- Multiple pregnancy

- Placenta previa

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Oxytocin

Dinoprostone

Procedure:
Membrane sweeping


Locations

Country Name City State
Korea, Republic of Department of Obstetrics and Gynecology Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vaginal delivery within 24 hours Vaginal delivery within 24 hours is defined as vaginal delivery after 24 hours of initiating intervention (i.e.concurrent membrane sweeping with dinoprostone or only dinoprostone) on the first day of induction. From the time of initiating intervention (i.e.concurrent membrane sweeping with dinoprostone or only dinoprostone) until the time of vaginal delivery, assessed up to 24 hours
Secondary Successful labor induction to achieve the active phase of labor corresponding to a cervical dilatation of >=4cm From the time of initiating intervention (i.e.concurrent membrane sweeping with dinoprostone or only dinoprostone) until the time of active phase of labor ( defined as a cervical dilatation of >=4cm), assessed up to 24 hours
Secondary Incidence of cesarean delivery From the time of initiating intervention (i.e.concurrent membrane sweeping with dinoprostone or only dinoprostone) until the time of cesarean delivery, assessed up to 120 hours End of labor induction (assessed up to 120 hours)
Secondary The interval from start of oxytocin to delivery From the time of initiating oxytocin infusion until the time of delivery, assessed up to 120 hours
See also
  Status Clinical Trial Phase
Completed NCT02618096 - Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Multiparous Women at Term N/A
Completed NCT01317706 - Comparison Between Ultrasonographic Cervical Length and Bishop Score in Preinduction Cervical Assessment N/A
Completed NCT01596296 - Foley Catheter Versus Dinoprostone Vaginal Insert for Induction of Labor in Parous Women at Term: A Randomized Trial N/A
Completed NCT02485821 - Vaginal Estradiol Pretreatment in Labour Induction With Misoprostol Phase 2/Phase 3
Completed NCT02314260 - Modifying Cervical Bishop Scoring System N/A
Completed NCT01317862 - A Comparison of Transcervical Foley Catheter and Prostaglandins for Induction of Labor at Term N/A
Completed NCT01506388 - A Novel Protocol for Labour Induction Phase 3
Completed NCT01317823 - Bishop Score and Transvaginal Ultrasound for Preinduction Cervical Assessment in Multiparas N/A
Completed NCT02524002 - Enhanced vs. Routine Clear Liquid Intake in Labor N/A